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Microbial Methylotrophic Metabolism: Recent Metabolic
Modeling Efforts and Their Applications In Industrial
Biotechnology
Christian Lieven, Markus J. Herrgård, and Nikolaus Sonnenschein*
Developing methylotrophic bacteria into cell factories that meet the chemical
demand of the future could be both economical and environmentally friendly.
Methane is not only an abundant, low-cost resource but also a potent
greenhouse gas, the capture of which could help to reduce greenhouse gas
emissions. Rational strain design workflows rely on the availability of carefully
combined knowledge often in the form of genome-scale metabolic models to
construct high-producer organisms. In this review, the authors present the
most recent genome-scale metabolic models in aerobic methylotrophy and
their applications. Further, the authors present models for the study of
anaerobic methanotrophy through reverse methanogenesis and suggest
organisms that may be of interest for expanding one-carbon industrial
biotechnology. Metabolic models of methylotrophs are scarce, yet they are
important first steps toward rational strain-design in these organisms.
1. Introduction
Methane, the primary component of shale gas, natural gas and
biogas, is an abundant, albeit highly distributed, and small-scale
resource.[1] A powerful greenhouse gas, its release from
decomposing landﬁll and agricultural waste, gas ﬂares, and
wastewater treatment plants into the atmosphere contributes
strongly to global warming.[2] The output from these sites can be
captured and the carbon, that is currently wasted, can
sustainably be converted into value-added chemicals, fuels or
electricity by means of microbial activity. To illustrate, the
amount of carbon released from global venting and ﬂaring in
2014 alone would have been sufﬁcient to cover the world’s
requirement for methanol, ethylene, propylene, butadiene,
xylene, benzene, and toluene.[1] In addition to the environmental
beneﬁts of carbon capture at these sites, the price of methane is
lower and its per-carbon yield higher than
that of glucose, making it the ideal
substrate for cell factories.[3] Consequently,
public and private funding, and thus
general research in this area has increased.
Pieja et al.[4] have reviewed a number of
studies that explore potential gas-to-prod-
ucts technologies using methanotrophic
organisms. Methanol, which is the ﬁrst
product of aerobic methane oxidation,
presents a similarly suitable feedstock for
biotechnological applications. Strategies
involving native methylotrophs have been
reviewed by Clomburg et al.,[1] while
achievements in synthetic implementa-
tions ofmethylotrophy have been expanded
upon by Bennett et al.[2] To rationally
improve strain designs of native and
synthetic methanotrophs, in silico systems
biology tools can be employed.[5] The
fundament of many in silico approaches is a formalized
representation of an organism’s metabolic network in the form
of a genome-scale metabolic model (GEM).
Here in this review, we focus on organisms for which GEMs
are currently available in literature that could support the
development and improvement of industrial producer strains,
which convert methane or methanol into value-added com-
pounds. Elsewhere, a similar effort has been carried out
investigating genome-scale metabolic models of clostridia,
which are the relevant biocatalyst of syngas (CO2, CO, H2)
fermentations.[6]
2. Underlying Principles of Genome-Scale
Metabolic Modeling
Constraints-based reconstruction and analysis (COBRA) of meta-
bolic networks has become a widely adopted discipline of systems
biology in the past two decades.[7] From the sequenced genome of
any given organism, information about the speciﬁc enzymatic
reactions can be extracted and translated into a set of stoichiometric
equations. These equations are then viewed as a closed system,
which is mass-, and ideally, charge-balanced. Moreover, it is
assumed that the system is at a steady state,meaning that there isno
net accumulationof intracellularmaterial.Basedon thesepremises,
the internal metabolic ﬂuxes of an organism can be expressed as:
Sv¼ 0 a linear systemof equationswhere thematrixS represents all
stoichiometric coefﬁcients from the set of enzymatic reactions, and
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the vector v represents the ﬂux distribution across all reactions (see
Figure 1). Flux balance analysis (FBA) can then be used to obtain a
speciﬁc ﬂux distribution, typically one that maximizes the ﬂux
through a speciﬁc reaction, for instance the biomass equation.[8]
A well-curated genome-scale metabolic network by itself is a
powerful knowledgebase as it accounts for the interconnection
between genes, reactions, metabolites, and databases cross-
references (meta-information).[9] Built on top of this, FBA and
derivative methods have been shown to accurately predict
growth phenotypes. Thus, they are useful to prospect strategies
for metabolic engineering in silico.[10] One example for the
successful integration of a genome-scale metabolic model and
metabolic engineering is the development of an E. coli strain
capable of producing 1,4-butanediol,[11] the design of which
relied on the available GEM at the time[12] and an algorithm for
the prediction of biological pathways to a speciﬁc target
compound.[13] The high-level production strain developed based
on this design has entered commercial production in 2016
representing one of the rare instances where non-native
commodity chemicals are produced by the fermentation route
commercially (www.novamont.com/eng/read-press-release/
mater-biotech/). Many other fruitful applications of GEMs and
COBRA methods have been reported, although chieﬂy for the
model organisms Escherichia coli and Saccharomyces cerevisiae.[14]
3. State of the Art: Existing C1 Metabolic
Models
3.1. GEMs for Aerobe Methanotrophy
Nature has found two distinct ways of breaking the strong bond
between the carbon atom and one of the four hydrogen atoms of
methane.[15] In aerobic methanotrophs, two types of methane-
monooxygenases can catalyze this reaction, converting methane
and oxygen to methanol and water (Figure 2). Few organisms
express a soluble monooxygenase (sMMO), which receives the
electrons necessary for oxidation from NADH. In a majority of
methanotrophs, however, the reaction is carried out by a
membrane-bound, so called particulate methane-monooxyge-
nase (pMMO). While it also requires two electrons to carry out
the oxidation of methane, its native reductant is still debated.[16]
Three possible scenarios regarding the mode of electron transfer
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Figure 1. Stoichiometric models rely on biochemical and physical
assumptions. The stoichiometry of metabolic reactions can be translated
into a system of linear equations formally written as a stoichiometric
matrix (S-Matrix). Four common assumptions help reduce the solutions
that can be found for this system: 1. There is no change inmass over time,
2. The solutions have to be thermodynamically feasible, 3. Enzymes are
limited in their capacity, and 4. A cellular objective mimics a specific
metabolic phenotype. Together, these assumptions allow i.e., the
calculation of product yield at different specific growth rates μ.
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can be considered (Figure 3): 1) electrons needed for the
oxidation of methane are supplied by NADH produced from
formaldehyde oxidation further downstream, while the electrons
from methanol oxidation are shuttled into ATP production via a
redox arm composed of cytochromes; 2) The pMMO is directly
coupled to the methanol dehydrogenase, which allows an
immediate exchange of electrons between the two reactions;
3) In the so called uphill electron transfer electrons are supplied
to the pMMO by MDH and NADH.[17]
With the genome-scale metabolic model of Methylomicrobium
buryatense 5G(B1), de la Torre et al.[18] presented the ﬁrst ever
manually curatedGEMofamethane-utilizingbacterium.Using the
model to explore each mode of electron transfer, they were able to
eliminate the redoxarmhypothesisas it correlated the leastwith their
experimental measurements for M. buryatense. Further, the
researchers found that the in silico replacement of the pyruvate
dehydrogenase with a phosphoketolase did not improve the overall
carbon yield on methane. Instead a decrease in carbon yield was
predicted since more methane was oxidized to CO2 as a source of
NADH. The genome scale metabolic model complements the
genetic tools that have already been established forM. buryatense,[19]
and recent successes in metabolic engineering show that there is
potential to commercialize the production of chemicals in M.
buryatense. For instance,Donget al.[20] havebeenable to increase the
production of membrane phospholipids, which they subsequently
processed into diesel blendstock, and Henard et al.[21] have used
M.buryatense toproduce lactateat a yieldof0.05 g lactate/gmethane.
In addition, the latter have been able to improve the lipid and
biomass yield 2.6-fold by overexpressing the phosphoketolase.[22]
AGEMof thehalotolerantMethylomicrobiumalcaliphilum20ZR
is also available from the Kalyuzhnaya Lab.[23] The authors
gathered metabolomics proﬁles of M. alcaliphilum grown on
methane and methanol to verify and improve the in silico
predictions. The model correctly predicted an increase in the
metabolite pools of amino acidswhen grown onmethanol instead
of methane. Furthermore, simulations indicated that during
oxygen-limited growth pyrophosphate-dependent reactions play
an important role to improve the biomass yield. Lastly, they
determined that a direct coupling electron transfer mode ﬁt best
their observations. In previous studies, the organismwas found to
ferment methane-derived formaldehyde to organic acids at low
oxygen tension,[24] andwasused to investigate thebiosynthesis and
degradationpathwaysof sucrose inmethanotrophs.[25]Hill et al.[26]
successfully co-cultivatedM. alcaliphilum 20Zwith Synechococcus
PCC 7002 on a mixture of methane and carbon dioxide. This
approach avoids the need to control the ratio ofmethane to oxygen
like it is the case in methanotroph monocultures. A promising
industrial application involving M. alcaliphilum 20Z is the
production of the osmolyte and biostabilizer ectoine. One
kilogram of ectoine costs around US$ 1000, with the average
global demand of the pharmaceutical industry amounting to
15 000tonnesperyear.[27]TheGEMforM.alcaliphilum20ZRcould
be employed to evaluate ectoine production and develop
hypothesis-driven strain engineering strategies in this organism.
The production of animal feed from natural gas using
Methylococcus capsulatus as the provider of single cell protein
(SCP) had already been commercialized in the 70s until a drop in
oil prices made these efforts economically infeasible. Today, at
least two companies produce SCP in this manner at pilot scale
with commercial scale plants in the process of being constructed,
among them US-based Calysta (www.calysta.com) and
Denmark-based Unibio (www.unibio.dk).[28] In addition to
SCP, early stage work has been done to develop M. capsulatus
as a production host for several commodity chemicals. Examples
include propylene by Calysta,[29] succinate by String Bio,[30] 1,4-
butanediol by Sekisui Chemical[31] and other multi-carbon
compounds by the Intrexon Corporation.[32]
Although M. capsulatus has been extensively studied in the
past 50 years,[33] a curated GEMwas only recently completed by a
group that included the authors of the present review.[34] We
computationally predicted transporter genes and assigned them
to corresponding transport reactions. Similar to the efforts
carried out by de la Torre et al.[18] for M. buryatense, we
investigated which mode of electron transfer best represents
measured parameters for Methylococcus capsulatus. We found
that simulations of the three modes exclusively could not
adequately represent the experimentally observed ratio of O2
uptake per mol of methane. Only by reducing the efﬁciency of
the uphill electron transfer mode we were able to replicate the
reference ratio. Moreover, we found that the energetic burden of
NH4 oxidation to NO2 by the pMMO likely affects this ratio,
when cells are grown on medium containing NH4 as the
nitrogen source. To facilitate visual inspection of multi-omics
data andmore intuitive exploration of themetabolic potential, we
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Figure 2. Comparison of the stoichiometry of MCR, sMMO, and pMMO.
Nickel (Ni), Iron (Fe) and Copper (Cu) activate a C-H bond of methane in
MCR, sMMO and pMMO respectively. While the sMMO and pMMO
require two electrons to activate molecular oxygen, the anaerobic
methane oxidation catalyzed by MCR does not require additional energy.
This figure was adapted from [35]gr2
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Figure 3. Three hypotheses describe the electron transfer to the
particulate Methane Monooxygenase. 1. Redox-arm: Electrons released
from the methanol dehydrogenase (MEOHDH) contribute to building up
the protein motive force. The oxidation of formaldehyde to carbon dioxide
provides the electrons for the oxidation of methane. 2. Direct coupling:
The MEOHDH passes electrons directly to the pMMO. 3. Uphill electron
transfer: Electrons from the MEOHDH can reach both the terminal
oxidase and the pMMO.
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also provide ametabolic map that displays themetabolic network
described by the model.
3.2. GEMs for Methylotrophy
Despite being more reduced, the hypothetical per carbon
substrate yields of methane have been determined to be
consistently lower than those of methanol in an in silico study
carried out by Comer et al.[3] This is due to the low efﬁciency
conversion catalyzed by the methane monooxygenase. Natural
aerobic methane oxidation requires two electrons, which
subsequently have to be recovered by the methanol dehydroge-
nase, oxidizing methanol to formaldehyde, or further down-
stream depending on the mode of electron transfer.[1] This
contributes to losing 36% of the energy within the highly
reduced molecule by an essentially redox-neutral conversion of
methane to formaldehyde.[35] Methanol is an intermediate of
methanotrophy, therefore many methanotrophs can use it as
their sole carbon and energy source. Since it is a liquid, using
methanol bypasses potential issues with mass-transfer during
gas-fermentation. Although less environmentally friendly than
biocatalysis, a recent breakthrough allows the production of
methanol by way of chemical conversion from methane at
milder conditions than previously possible.[36] This could
increase the role of methanol as a one-carbon feedstock.
The metabolism of the facultative methylotroph
Methylobacterium extorquens AM1 has been studied in detail
since well over 50 years.[37] The considerable research interest
has resulted in the development of genetic tools and protocols,
ultimately leading to the establishment of several production
processes, the products of which include polyhydroxyalkanoates
(PHA), serine, dicarboxylic acids derived from the ethylmalonyl-
CoA pathway, alcohols, and proteins.[38] A GEM was established
for M. extorquens AM1 to investigate the topology and operation
of the intertwined metabolic cycles that operate in the bacterium
when grown on methanol.[39] In a separate study, researchers
succeeded in heterologously producing 1.65 g L1 of α-homu-
lene, an anti-inﬂammatory terpenoid, in M. extorquens. The
metabolic model was used to calculate the maximum theoretical
yield of the compound.
3.3. GEMs for Anaerobic Methanotrophy
In addition to the energy loss caused by the oxygen-dependent
conversion of methane mentioned above, the volumetric mass
transfer of methane and oxygen is another limitation especially
at large-scale operation. Although innovative specialized reactor
designs alleviate the issue,[40] they translate into increased capital
expenses when compared to using regular stirred-tank vessels.
With respect to these drawbacks, anaerobic production of
chemicals from methane is considered more ideal, despite the
issue with lower growth rates and productivities of microbes
under these conditions.[2]
The methyl-coenzyme M reductase (MCR) is the key enzyme
required for the anaerobic biosynthesis of methane. In this
reaction, methyl-coenzyme M (methyl-SCoM) reacts with
coenzyme B (CoBSH) to form methane and COBS-SCoM.[16]
Anaerobic methanotrophs (ANME) have a homolog MCR that is
able to catalyze the reverse reaction (Figure 2). In nature, ANME
grow in consortia with syntrophic bacteria that participate in the
removal of reducing equivalents, which has complicated the
isolation and culturing of native ANME strains.[2] However,
through metagenomic sequencing it was recently possible to
obtain the corresponding MCR gene, successfully clone,
and express it in the methane-producing archaeon
Methanosarcina acetivorans C2A.[41] Nazem-Bokaee et al. pub-
lished iMAC868,[42] an update to the two previously existing
GEMs for M. acetivorans, iVS941[43] and iMB754.[44] Using
iMAC868, the authors studied the feasibility of producing
acetate, formate and pyruvate on methane as a function of Fe3þ
reduction. They further improved the predictions of growth yield
on the native substrates methanol and acetate, in addition to
making the necessary changes to enable methanotrophy. The
authors predicted the hypothetically maximal biomass yields and
the yields of biofuel precursors methanol, ethanol, butanol, and
isobutanol onmethane. Considering theΔGof different external
electron acceptors, they found that the yields were highest for
Fe3þ reduction when CO2 in the form of bicarbonate was co-
utilized. The native products of reverse methanogenesis in A.
acetivorans were determined to be acetate and CO2. Using the
same engineered host, McAnulty et al.[45] produced lactate
yielding 0.59 g per gram of methane. This is an order of
magnitude greater than the previously reported yield of lactate
on methane in an aerobic process.[21]
Bennett et al.[2] suggest that as there are genetic tools available
for it, the hydrogenotrophic methanogen Methanococcus
maripaludis could also be consider as a host for reverse
methanogenesis. Several metabolic models currently have been
reconstructed for this archaeon with the most recent one being
iMR539.[46]
3.4. Approaches for Synthetic Methanotrophy
Slow growth rates, inefﬁcient molecular techniques and a lack of
experience compared to model microorganisms complicate the
work with native aerobic and anaerobic methanotrophs. While
the implementation of aerobic methane oxidation using pMMO
or sMMO has been difﬁcult,[47,48] the transfer of precursor
pathways belonging to anaerobic methanotrophy has been
successful,[49] thus making the prospect of synthetic anaerobic
methanotrophy promising. Most progress, however, has been
made with the heterologous expression of methylotrophic
genes in the microbial workhorses Escherichia coli,
Corynebacterium glutamicum and Saccharomyces cerevisiae.[2] It
is no surprise that GEMs for these three well-established model
organisms exist and are continuously updated. For reference, the
most recent versions are listed in Table 1.
Another promising option, which can be regarded as a step
toward heterologous methanotrophy, is the development of
synthetic pathways involving novel enzymes.[10] The formolase
pathway, which has been constructed around the computation-
ally designed enzyme formolase (FLS), is such a pathway.
Overall, the ﬁve-step, linear pathway catalyzes the carboligation
of three formate molecules into the common three-carbon
intermediate dihydroxyacetylphosphate (DHAP) and has been
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shown to function in vitro.[50] The authors used ﬂux balance
analysis and the coremetabolic model of E. coli[51] to compare the
performance of their novel pathway relative to all natural formate
assimilation pathways. They found that the hypothetical
maximum biomass yield of the formolase pathway is the second
highest (6.5 g cell dry weight/mol formate) behind the reductive
TCA cycle (6.7 g cell dry weight/mol formate), but exceeds all
other pathways when considering the chemical driving force.
4. Conclusions
Although the true impact of genome-scale metabolic models in a
speciﬁc ﬁeld of research is hard to quantify, their general success
is indisputable.[52] A well-curated GEM is particularly useful for
exploring the topology and systems properties of metabolism. In
addition, aGEMestablishes a connection between stoichiometric,
genetic, and meta-information which is the foundation of many
strain-designmethods.However, there are systemic limitations. A
high-quality GEM requires the existence of a carefully annotated
genome sequence. An incomplete sequence or erroneous
annotation will introduce a bias in the resulting model.[53] The
steady state assumption means that dynamic processes such as a
change in metabolite concentration cannot be accounted for.
Similarly, the effects of regulation can only be applied deliberately
e.g., through the use of additional constraints.[34]
While four available GEMs for aerobic methyl- and methano-
trophy reported here have been used to explore metabolic
interconnections and the system’s behavior in speciﬁc con-
ditions using constraint-basedmodeling, further cross validation
against experimental data could improve their predictiveness. As
Table 1. Genome-scale metabolic models relevant to methano- or methylotrophy.
Organism Model ID Previous Versions # Reactions # Metabolites # Genes Reference
Aerobic
Methylobacterium extorquens AM1 iRP911a) First 1139 977 911 [63]
Methylococcus capsulatus Bath iMcBath a, c) First 898 877 730 [34]
Methylomicrobium alcaliphilum 20Z iIA407 b) First 433 423 407 [23]
Methylomicrobium buryatense 5G(B1) iMb5G(B1)a, b) First 402 403 314 [18]
Anaerobic (Chassis for Reverse Methanogenesis)
Methanococcus maripaludis S2 iMM518b) First 570 556 518 [56]
Methanococcus maripaludis S2 iMR539a, c) Independent from iMM518 688 710 539 [46]
Methanosarcina acetivorans C2A iMAC868b) iVS941d), iMB745e) 845 718 868 [42]
Sythetic Methano- or Methylotrophy
Corynebacterium glutamicum iCW773b) Reviewed in [64] 1207 950 773 [65]
Eschericia coli iML1515a) Reviewed in [66] 2712 1877 1516 [67], Used in [3,68]
Sacharromyces cerevisiae YEAST 7a, c) Reviewed in [69] 3493 2220 909 [70], Used in [3]
a) Available as SBML; b)Available as XLS; c)Available as MAT, d)[43]; e)[44].
Table 2. Methanotrophs that are potentially relevant as biotechnological producers.
Organism Genome Sequence Primary Interest
Methylobacter marinus 7C [71] Identification of the ectoine biosynthesis genes[72]
Methylobacterium organophilum CZ-2 Not sequenced Production of PHB[73] and triacylglycerides[27]
Methylocaldum sp. SAD2 Not sequenced Production of methanol on high levels of H2S
[74]
Methylocapsa acidiphila Direct submission NZ_ATYA00000000.1 Potential production of PHB[75]
Methylocella tundrae Not sequenced Production of methanol[76]
Methylocystis bryophila Direct submission NZ_CP019948.1 Production of methanol[77]
Methylocystis parvus OBBP [78] Production of PHB[79]
Methylocystis sp. WRRC1 Not sequenced Production of a copolymer of PHB and hydroxyvalerate[80]
Methylomicrobium kenyense AMO1 Not sequenced Identification of the ectoine biosynthesis genes[72]
Methylomonas denitrificans [81] Production of N2O coupled to methane oxidation under hypoxia
[81].
Methylomonas sp. 16a Sequenced by DuPont, unpublished Synthesis of C30 carotenoids,[82] production of astaxanthin and canthaxanthin[83,84]
Methylosinus sporium Not sequenced Production of methanol[85]
Methylosinus trichosporium OB3b [86] Production of methanol[87]
PHB, polyhydroxybutyrate.
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such the analysis of model predictions versus data from genetic
perturbation (i.e., knockout) experiments in addition to growth
studies is an invaluable step.[9,54]
Promiscuous enzyme functions are often not included in
biochemical databases and rarely covered in the genome
annotation.[55] While the methanogen models iMM518,[56]
iMR539,[46] and iMAC868[42] have been validated using small-
scale knockout data, the use of this method of validation for a
GEM of a methanotroph has been limited to a single reaction
knockout in iIA407.[23] Yet, Richards et al.[46] point out that this is
made difﬁcult by a low abundance of suitable gene knockout
data.
The application of computational strain design methods in
this ﬁeld has not been reported so far. A host of strain design
methods have been thoroughly reviewed by Ng et al.[5] Applying a
pathway prediction method such as GEM-Path, for instance,
could decrease the time required to create a suitable design for
the production of commodity chemicals from methane. The
algorithm provided 1271 growth-coupled designs for the
production of 20 commodity chemicals in E. coli.[57] Using the
metabolic models that are currently available for methanotrophs,
the production potential of the organisms could already be
explored.
Lastly, many of the discussed GEMs are distributed in a non-
standard, tabular ﬁle format (Table 1). While the MATLAB
version of the COBRA Toolbox is able to import and simulate
models that come in this format, other software tools rely on the
communication of models in the Systems Biology Markup
Language (SBML). In fact, Ravikrishnan & Raman (2015)
advocate the distribution of models in this de facto community
standard, because the use of other formats may decrease
reproducibility and the ability to use a GEM with the largest
portion of available tools.[58]
As evident from this review, metabolic models of methano-
trophy are scarce and their potential yet untapped. In the future,
many more organisms than the ones reviewed here could
become relevant as methanotrophic producer strains, and thus
could beneﬁt from having a GEM available. Potential organisms
of interest formethanotrophic production are collected in Table 2
with references to the corresponding genome sequences and
publication describing a potential use of the organism for
production.
Although the applicability of the organisms in Table 2 is not
certain, merely having access to curated biochemical informa-
tion could serve the scientiﬁc community as a whole. As Monk
et al. remark, the coverage of metabolic reactomes has stagnated,
since little effort is spent on comprehensively uncovering the
metabolic space of an organism, especially with regards to the
secondary metabolism.[59] A thorough analysis of these
organisms may lead to interesting discoveries similar to, for
instance, that of hopanoid production in M. capsulatus and
Alicyclobacillus acidocaldarius.[60]
Moreover, the use of novel formalisms could allow future
reﬁnement of the GEMs presented herein. For instance,
including reactions that describe the mechanistic processes
involved in gene expression and protein biosynthesis allows
simulating metabolic tradeoffs in energy allocation and the
prediction of the organism’s maximum growth rate.[61] Due its
complexity the lipid metabolism in GEMs is typically
represented by lumped reactions, which involve either an
artiﬁcial average or the most dominant type of fatty acid. Adding
special pseudo-reactions based on data from lipid proﬁling and
fatty acid methyl ester analysis could further help to improve the
representation of the lipid metabolism.[62]
Despite the minor shortcomings noted above, the availability
of these models can only serve to accelerate the process of
discovery. GEMs allow researchers to probe certain properties in
silico isolated from the potential challenges associated with slow
growth, difﬁculties to culture an organism, and inefﬁciencies of
molecular techniques or even the lack thereof. Hence, they
represent an ideal tool to explore and expand the metabolic
potential of methanotrophs.
The ﬁrst steps, presented here, may lead towards a solid
foundation for rational strain-design ofmethanotrophs, andmay
help to elucidate their many properties.
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